Warning
Apotex Corp. Recalls Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0407-2026Drug / Pharmaceutical
Apotex Corp. Recalls Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution
Apotex Corp. · Class II — Moderate Risk
Product Description
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.
Reason for Recall
Lack of Assurance of Sterility
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
U.S. Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Apotex Corp. has recalled a pharmaceutical product that the FDA classified as Class II affecting 107,136 vials. The recall was initiated on March 5, 2026. Lack of Assurance of Sterility. It was distributed in U.S. Nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.